CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
about
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosisBalancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza InfectionPC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.Tissue-protective effects of NKG2A in immune-mediated clearance of virus infection.High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection.Preferential migration of effector CD8+ T cells into the interstitium of the normal lung.Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus.Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice.A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.Interference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infectionICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejectionADAM17-mediated processing of TNF-α expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury.A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus InfectionManipulation of immunity to and pathology of respiratory infections.CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure.Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury.Acrolein - a pulmonary hazard.Human CD8(+) T Cells Damage Non-infected Epithelial Cells During Influenza Virus Infection In Vitro.Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury.The protective effects of intranasal administration of IL-12 given before influenza virus infection and the negative effects of IL-12 treatment given after viral infection.Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus.Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand.Effects of peritoneal fluid from endometriosis patients on the release of monocyte-specific chemokines by leukocytes.
P2860
Q24811707-75A77FAB-2027-4680-A959-C675489469AAQ26767517-A2A8D816-CA9F-4E15-98CA-EBA28D1AB891Q30353758-7C9EE1CF-649F-4CA4-A151-A34D61A17DDDQ30410322-B7D560B6-9AFE-4FEE-ABEF-75363F10A79AQ30422635-E2D8AD57-5926-4BC3-83DE-5BA31FBDD425Q30438791-125977BA-6AEC-4BBD-8112-63ED62189857Q33843485-EEE78BD3-7DF7-41F7-BE19-01CE851BEAB0Q33938356-CC0AD649-8E4A-4566-81F7-C29380CC938FQ34187000-610B0587-8472-43D6-87FD-C5AA54898E0CQ34347141-E7E1ECCD-6114-4F1E-B512-EBC67FC97BD5Q34965591-29564F78-84C4-4D4A-8CFC-4CC0520067B0Q35040269-2A6FC1C7-AB59-4113-987C-E9484F45F898Q35905711-B3F26096-1D4B-48DA-93CE-5598E15CBAACQ35917430-4209DED1-C3B3-4F48-BB5B-2D425E9559ECQ36275096-9E961F39-1BE6-4435-A0F7-005D9EE50C38Q36376247-B66E2E6D-5EBC-4371-8CC9-1970CA7420CCQ37358025-059BE0F4-36F1-448D-902C-FBDD498D1BBCQ37455704-0B58A159-A43F-45DE-A3D8-D5E6C804519BQ37945138-A1FBFC67-38C7-4EE5-8E83-07FAE9F5D612Q38725997-76286B9D-200D-473A-944E-08AEB01EA286Q40756519-92ADBDEC-A618-4219-B9A6-0091E036064FQ40796643-4F3244D6-D4A3-4671-8ADD-E43D798D6345Q44354620-2505ABA4-5C75-493F-9A41-0710311FAF00Q47752245-54B18564-D62B-4F25-BC50-460E26DE1DB4Q51681331-F323A7AF-2B9D-4D4F-BA75-B21CD3C5AFBB
P2860
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@ast
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@en
type
label
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@ast
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@en
prefLabel
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@ast
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@en
P2093
P2860
P356
P1476
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
@en
P2093
C W Lawrence
M H Stoler
R I Enelow
S A Dressel
T J Braciale
P2860
P304
P356
10.1084/JEM.194.12.1835
P407
P577
2001-12-01T00:00:00Z